Lemonaid Health

About Lemonaid Health

Lemonaid Health takes a deliberately simple approach to GLP-1 access: skip the insurance hassle, pay cash, get your medication fast. Founded in 2013 and now part of 23andMe, the platform leverages its parent company’s health-data expertise while maintaining a lean, efficient prescription service.

The medication menu includes both brand-name options (Ozempic, Wegovy) and compounded semaglutide for patients seeking a lower-cost alternative. Monthly pricing starts at $49/month plus $299 for medication, positioning Lemonaid in the mid-range for total cost. The self-pay model eliminates insurance paperwork — appealing for patients who want speed over savings from coverage.

Lemonaid’s association with 23andMe adds a unique dimension. While the GLP-1 program itself doesn’t directly integrate genetic data, the parent company’s emphasis on data-driven health decisions informs the platform’s approach to clinical care. Fast shipping is a noted advantage — patients receive medications quickly once prescribed.

With a 4.3 Trustpilot rating across 190+ reviews and an A- BBB rating, Lemonaid demonstrates solid patient satisfaction and institutional trust. The review volume is on the lower side, but the quality metrics are encouraging.

The clinical program is straightforward — medium provider quality and ongoing support, with no lab testing or dietitian access included. This is by design: Lemonaid prioritizes efficient access over comprehensive care, making it best suited for patients who want a reliable prescription service rather than a full obesity management program.

At a Glance